Literature DB >> 9774969

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

A Yang1, M Kaghad, Y Wang, E Gillett, M D Fleming, V Dötsch, N C Andrews, D Caput, F McKeon.   

Abstract

We describe the cloning of p63, a gene at chromosome 3q27-29 that bears strong homology to the tumor suppressor p53 and to the related gene, p73. p63 was detected in a variety of human and mouse tissues, including proliferating basal cells of epithelial layers in the epidermis, cervix, urothelium, and prostate. Unlike p53, the p63 gene encodes multiple isotypes with remarkably divergent abilities to transactivate p53 reporter genes and induce apoptosis. Importantly, the predominant p63 isotypes in many epithelial tissues lack an acidic N terminus corresponding to the transactivation domain of p53. We demonstrate that these truncated p63 variants can act as dominant-negative agents toward transactivation by p53 and p63, and we suggest the possibility of physiological interactions among members of the p53 family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9774969     DOI: 10.1016/s1097-2765(00)80275-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  730 in total

1.  p53 Family members p63 and p73 are SAM domain-containing proteins.

Authors:  C D Thanos; J U Bowie
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

2.  Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27.

Authors:  P Ianakiev; M W Kilpatrick; I Toudjarska; D Basel; P Beighton; P Tsipouras
Journal:  Am J Hum Genet       Date:  2000-06-05       Impact factor: 11.025

3.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

4.  Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.

Authors:  Takahito Nakagawa; Masato Takahashi; Toshinori Ozaki; Ken-ichi Watanabe Ki; Satoru Todo; Hiroyuki Mizuguchi; Takao Hayakawa; Akira Nakagawara
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Transcriptional activities of p73 splicing variants are regulated by inter-variant association.

Authors:  Y Ueda; M Hijikata; S Takagi; T Chiba; K Shimotohno
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

6.  Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.

Authors:  Yi Zhang; Yan Cheng; Xingcong Ren; Tsukasa Hori; Kathryn J Huber-Keener; Li Zhang; Kai Lee Yap; David Liu; Lisa Shantz; Zheng-Hong Qin; Suping Zhang; Jianrong Wang; Hong-Gang Wang; Ie-Ming Shih; Jin-Ming Yang
Journal:  Cancer Res       Date:  2012-06-04       Impact factor: 12.701

7.  RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability.

Authors:  Jin Zhang; Seong Jun Cho; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

Review 8.  The role of p53 gene family in reproduction.

Authors:  Wenwei Hu
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

9.  Mutation and expression of the p51 gene in human lung cancer.

Authors:  M Tani; K Shimizu; C Kawahara; T Kohno; O Ishimoto; S Ikawa; J Yokota
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

10.  ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear transport and squamous cell carcinoma proliferation.

Authors:  Masaharu Hazawa; De-Chen Lin; Akiko Kobayashi; Yan-Yi Jiang; Liang Xu; Firli Rahmah Primula Dewi; Mahmoud Shaaban Mohamed; Mitsutoshi Nakada; Makiko Meguro-Horike; Shin-Ichi Horike; H Phillip Koeffler; Richard W Wong
Journal:  EMBO Rep       Date:  2017-12-07       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.